← Back to GLMD

Galmed Pharmaceuticals Ltd. - Ordinary Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 02/09/2026Mar 2026Filed 02/09/2026Sep 2025Filed 26/11/2025Jun 2025Filed 02/09/2026Mar 2025Filed 02/09/2026Sep 2024Filed 26/11/2025Jun 2024Filed 28/08/2025Mar 2024Filed 28/08/2025
−$2.7−$1.9−$1.9−$2.5−$1.1−$1.9−$1.1−$1.3
$2.86$0.33$5.06$2.31$1.65
15.50.50.80.7

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.